Supernus Pharmaceuticals Inc. (SUPN)
Market Closed
16 Oct, 08:00 PM
$
37. 88
-1.69
-4.2709%
$
2.21B Market Cap
64.88 P/E Ratio
- Div Yield
1.44M Volume
2.16 Eps
$ 39.57
Previous Close 
Want to track SUPN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Supernus Pharmaceuticals Inc. (SUPN) Statistics
Valuation metrics
Market Cap 2.21B
Enterprise value 2.34B
Trailing P/E (ttm) -22.21
Forward P/E 11.73
PEG ratio 0.21
Price/Sales (ttm) 2.98
Price/Book (mrq) 2.4
Enterprise Value/Revenue 2.81
Enterprise Value/EBITDA -147.26
Overview
Shares outstanding 57.46M
Float 52.25M
Shares short 4.72M
% Held by insiders 0.04%
% Held by institutions 1.03%
Average volume (10 days) 643.8K
Average volume (90 days) 857.34K
Price summary
52-Week low 37.54
52-Week high 59.68
Beta 0.57
50-Day moving average 42.91
200-Day moving average 48.03
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -0.13%
Operating margin -0.13%
Operational effectiveness
Return on assets -0.08%
Return on equity -0.1%
Income Statement
Revenue (ttm) 776.83M
Revenue per share (ttm) 14.3
Quarterly revenue growth (yoy) 0.39%
Gross profit (ttm) 575.9M
EBITDA 67.95M
Net income to common (ttm) -29.02M
Diluted EPS (ttm) -1.89
Quarterly earnings growth (yoy) 0.21%
Balance Sheet
Total cash (mrq) 384.24M
Total cash per share (mrq) 6.41
Total debt (mrq) 40.9M
Total Debt/Equity (mrq) 0.04
Current ratio (mrq) 2.08%
Book value per share (mrq) 17.76
Cash Flow
Cash flow statement 83.26M
Levered free cash flow (LFCF) 132.62M
2026 © Marketlog. All Rights Reserved.
